Lataa...
Targeting of albumin-embedded paclitaxel nanoparticles to tumors
We have used tumor-homing peptides to target abraxane, a clinically approved paclitaxel-albumin nanoparticle, to tumors in mice. The targeting was accomplished with two peptides, CREKA, and LyP-1 (CGQKRTRGC). Fluorescein (FAM)-labeled CREKA-abraxane, when injected intravenously into mice bearing MDA...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2824435/ https://ncbi.nlm.nih.gov/pubmed/18829396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2008.07.007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|